{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEGL-21029 NIPT Screening for Down's Syndrome Edward's and Patau's 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "NON-INVASIVE PRENATAL TESTING (NIPT) SCREENING FOR DOWN'S SYNDROME (T21), EDWARDS' SYNDROME (T18) AND PATAU'S SYNDROME (T13)"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEGL-21029"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, obstetricians"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "20 October 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "19 October 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Screening, Prenatal Testing, Down's Syndrome, Edwards' Syndrome, Patau's Syndrome"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "Recommendations from the UK National Screening Committee"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Division 7"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Neate / Bethany Broadhurst / Emma Connolly"
                    },
                    {
                        "text": "Antenatal Newborn Screening Co-ordinators at Broomfield, Basildon and Southend"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Maternity and Gynaecology Policy Working Group"
                    },
                    {
                        "text": "08 October 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Mandeep Singh"
                    },
                    {
                        "text": "Medical Director"
                    },
                    {
                        "text": "30 September 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "19 October 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "November 2021"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEGL-21029 NIPT Screening for Down's Syndrome Edward's and Patau's 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Mandeep Singh"
                    },
                    {
                        "text": "Medical Director \u2013 Women's and Children's Division"
                    },
                    {
                        "text": "30 September 2021"
                    },
                    {
                        "text": "Paula Hollis"
                    },
                    {
                        "text": "Head Of Midwifery- Southend"
                    },
                    {
                        "text": "30 September 2021"
                    },
                    {
                        "text": "Sharon Murrell"
                    },
                    {
                        "text": "Head of Midwifery-Broomfield"
                    },
                    {
                        "text": "30 September 2021"
                    },
                    {
                        "text": "Karradene Aird"
                    },
                    {
                        "text": "Head of Midwifery- Basildon"
                    },
                    {
                        "text": "30 September 2021"
                    },
                    {
                        "text": "Valerie King"
                    },
                    {
                        "text": "Practice Development Midwife"
                    },
                    {
                        "text": "30 September 2021"
                    },
                    {
                        "text": "Kate Palmer"
                    },
                    {
                        "text": "Practice Development Midwife"
                    },
                    {
                        "text": "30 September 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Committee if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Screening Co-ordinators across the MSE"
                    },
                    {
                        "text": "25 May 2021"
                    },
                    {
                        "text": "Maternity and Gynaecology Practice Steering Group"
                    },
                    {
                        "text": "22 July 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Down's Syndrome, Edward's and Patau's Screening or equivalent Antenatal and newborn screening tests or equivalent"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Neate, Bethany Broadhurst, Emma Connolly"
                    },
                    {
                        "text": "New MSE screening guideline to implement a new non-invasive prenatal testing for Edward's Down's and Patau's Syndrome"
                    },
                    {
                        "text": "20 October 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction to NIPT evaluative rollout ..................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities ........................................................................................ 5"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Screening .................................................................................................................... 6 6 Eligibility \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20266"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Blood sampling and transport ................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Reporting NIPT results ............................................................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "NIPT results ............................................................................................................... 10 10 Reporting terminology (must use NHS FASP terminology) .................................. 12 11 Managing NIPT results ............................................................................................. 12 12 Prenatal Diagnosis (PND) ........................................................................................ 13 13 Data requirements and monitoring ......................................................................... 13 14 NIPT performance .................................................................................................... 14 15 Screening safety incidents ...................................................................................... 15 16 Training Requirements ............................................................................................. 15 17 Guideline Management ............................................................................................ 15 18 Infection Prevention \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...  Monitoring and Audit \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u202616 20 Approval and Implementation \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.   Equality and Diversity \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026.  22 References ................................................................................................................ 16 Appendix 1: Patient information ..................................................................................... 17 Appendix 2: Preliminary Equality Analysis ................................................................... 1"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction to NIPT evaluative rollout"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "type": "table",
            "sequence_num": 18,
            "data": {
                "num_rows": 27,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "The UK National Screening Committee (NSC) recommended the introduction of"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "non-invasive prenatal testing (NIPT) as part of the NHS FASP screening pathway."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "This is an evaluative rollout so that any necessary changes to the pathway can be"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "made."
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "NIPT is a technique that is used to screen for T21, T18 and T13 during pregnancy."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "It involves taking a sample of blood from the woman."
                    },
                    {
                        "text": "1.3"
                    },
                    {
                        "text": "The maternal blood contains a mixture of maternal DNA and placental DNA. This is"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "known as the total cell free DNA (cfDNA). In most cases, the placental DNA will be"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "the same as the baby's DNA. The contribution of DNA from the placenta is called"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "cell free fetal DNA (cffDNA)."
                    },
                    {
                        "text": "1.4"
                    },
                    {
                        "text": "cffDNA can be detected in the maternal blood as early as 5 weeks of"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "pregnancy. cffDNA remains in the maternal blood for only a few hours after each"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "pregnancy, making it suitable for pregnancy-specific testing."
                    },
                    {
                        "text": "1.5"
                    },
                    {
                        "text": "Cells in the human body typically contain 46 chromosomes \u2013 23 from the mother"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "and 23 from the father. Each chromosome has sequences of DNA that are specific"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "to that chromosome. NIPT uses cffDNA in the maternal blood to assess the chance"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "of the baby having T21, T18 or T13."
                    },
                    {
                        "text": "1.6"
                    },
                    {
                        "text": "The majority of cfDNA comes from the woman, usually consisting of approximately"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "90% DNA from the woman's cells and 10% DNA from the placenta. If the baby"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "has T21, there should be slightly more chromosome 21 than expected from the"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "placental DNA (cffDNA) in the maternal blood. The same will apply for"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "chromosomes 18 and 13."
                    },
                    {
                        "text": "1.7"
                    },
                    {
                        "text": "The 2 testing methodologies eligible for assessment in the evaluative roll-out are:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Next generation sequencing technologies \u2013 for example, massively parallel"
                    },
                    {
                        "text": "shotgun sequencing (MPSS)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.8,
                "text": "NIPT does not analyse the DNA and does not detect any specific gene disorders, for example cystic fibrosis."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.9,
                "text": "This operational guidance is for people offering non-invasive prenatal testing (NIPT) screening  for  Down's  syndrome  (T21),  Edwards'  syndrome  (T18)  and  Patau's syndrome (T13) and includes information on:"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Eligibility for NIPT within NHS FASP"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Blood sampling and transport"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting NIPT results"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Operation procedures for three MSE sites"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Incident reporting"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to provide clear guidance on Non-invasive prenatal testing for staff within the MSE trust."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "type": "table",
            "sequence_num": 29,
            "data": {
                "num_rows": 14,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Term"
                    },
                    {
                        "text": "Definition"
                    },
                    {
                        "text": "CVS"
                    },
                    {
                        "text": "Chorionic villus sampling"
                    },
                    {
                        "text": "cf DNA"
                    },
                    {
                        "text": "Cell free DNA"
                    },
                    {
                        "text": "cff DNA"
                    },
                    {
                        "text": "Cell free fetal DNA."
                    },
                    {
                        "text": "PND"
                    },
                    {
                        "text": "Prenatal diagnosis"
                    },
                    {
                        "text": "ANTT"
                    },
                    {
                        "text": "Aseptic Non Touch Technique"
                    },
                    {
                        "text": "PHE"
                    },
                    {
                        "text": "Public health England"
                    },
                    {
                        "text": "NIPT"
                    },
                    {
                        "text": "Non Invasive Prenatal Testing"
                    },
                    {
                        "text": "FASP"
                    },
                    {
                        "text": "Fetal Anomaly Screening Programme"
                    },
                    {
                        "text": "T21"
                    },
                    {
                        "text": "Down's Syndrome"
                    },
                    {
                        "text": "T18"
                    },
                    {
                        "text": "Edward's Syndrome"
                    },
                    {
                        "text": "T13"
                    },
                    {
                        "text": "Patau's Syndrome"
                    },
                    {
                        "text": "NCARDRS"
                    },
                    {
                        "text": "National Congenital Anomaly and Rare Disease Registration Service"
                    },
                    {
                        "text": "DQASS"
                    },
                    {
                        "text": "Down's syndrome Quality Assurance Support Services"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "The Document Control Officer for Division 7 is responsible for ensuring clinical policies, guidelines and SOPs, reviewed according to the document control process  following appropriate consultation. The author / reviewer is responsible in ensuring  the documents are developed in line with national guidelines."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The Clinical Director is responsible for the implementation of this guideline within the directorate."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The Head of Midwifery, maternity matrons and maternity managers are responsible for ensuring maternity staff are aware of the guideline and implement it."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The Obstetric Clinical Lead Consultant and Labour Ward Lead Consultant are responsible for ensuring the implementation of this guideline within the clinical setting."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "All maternity staff are responsible for ensuring they are familiar with this guideline in relation to their practice and have the appropriate skills to implement this guideline."
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Screening"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "PHE Screening recommends the offer of NIPT screening for T21, T18 and T13, following a higher chance result from the combined or quadruple test in singleton and twin pregnancies. This can be offered up to 21+6 weeks."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "A higher chance result is between 1 in 2 and 1 in 150. Only increased chance results will qualify for NIPT screening on the NHS, this screening will be undertaken by the Screening Team and / or Fetal Medicine Unit."
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.3,
                "text": "As part of the NHS FASP care pathway NIPT screens for T21, T18 and T13 and will not screen for other chromosomal conditions or assess the baby's sex."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Following a higher chance result from the combined or quadruple test, women must have a discussion with a member of the screening team or fetal medicine team within three working days of increased chance results. This information can be discussed either on the phone or face to face; with the option of face to face discuss if women wish. Women can choose to have:"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No further testing"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT screening"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prenatal diagnosis (PND), such as chorionic villus sampling (CVS) or amniocentesis"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "For women choosing to have NIPT, the options would be:"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "T21, T18 and T13"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "T21 only"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "T18 and T13 only"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "NIPT screening will report individual chance results for T21, T18 and T13."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "During this discussion, women should be informed that the laboratory may"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "keep NIPT screening samples for quality assurance (for example, validation) and testing development purposes for up to 5 years. The healthcare professional should inform the laboratory if a woman does not want her sample to be kept for these purposes. These discussions (including the decision on the retention of samples) must be recorded in the woman's maternity notes / electronic records."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Eligibility"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "Inclusions"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.1 As part of the NHS FASP evaluative rollout, NIPT can be offered and performed:"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "When a woman receives a higher chance result for T21 or a joint higher chance result for T18 and T13 from the combined test"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "When a woman receives a higher chance result for T21 from the quadruple test"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In both singleton and twin pregnancies"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Up to  weeks and 6 days (21) of pregnancy"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.2 Women with in-vitro fertilisation (IVF) or donor egg pregnancies are eligible for the offer of NIPT. The relevant details must be recorded accurately on"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the NIPT screening request form."
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "Exclusions"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.2.1 As part of the NHS FASP evaluative rollout, NIPT cannot be offered and performed:"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "When a woman receives a lower chance result for T21, T18 or T13 from the combined or quadruple test"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In higher multiple pregnancies (triplets or more)"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "After 21 weeks of pregnancy"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.2.2 Also, NIPT cannot be offered and performed as part of the NHS FASP pathway when a pregnant woman has:"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cancer, unless in remission, as NIPT may detect cell free DNA (cfDNA) in the maternal blood which is released by a cancerous tumour"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Received a blood transfusion in the previous 4 months, as studies show that donor DNA in blood transfusion recipients lasts for several months, sometimes longer"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Had bone marrow or organ transplant, as donor DNA will be present"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Immunotherapy in the current pregnancy, excluding intravenous immunoglobulin (IVIg) treatment"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Had stem cell therapy, as this will depend on whether she has received her own stem cells or stem cells from a donor (certain methods of NIPT are not suitable for stem cell transplants)"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A vanished twin pregnancy (an empty second pregnancy sac or a second pregnancy sac containing a non-viable fetus), as there is evidence to suggest that the placenta can continue to shed cell free fetal DNA (cffDNA) even after the baby has died"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If the woman has Down's syndrome or a balanced translocation or mosaicism of T21, T18 or T13"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "Uncertain eligibility criteria"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To confirm eligibility for NIPT screening, contact the laboratory before taking"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a NIPT sample when the woman has any other chromosomal condition other"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 1,
                "text": "than T21, T18 or T13. This is because it may affect the analysis of NIPT. North Thames GLH (Health Service Laboratory (HSL)) 0207 3077409"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "Data fields for the NIPT laboratory request form"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT laboratory request forms must include, as a minimum, the required data fields outlined in NIPT screening request form: minimum data field requirements."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 1,
                "text": "NHS FASP recommends these minimum data fields are included when request forms are developed. Software and data entry methods may vary."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Blood sampling and transport"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Blood sampling"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The process for obtaining an NIPT blood sample is as outlined below:"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.1.1  The individual laboratory blood sample requirements are outlined below. North Thames GLH (Health Service Laboratory (HSL)) 0207 3077409 Two full tubes (minimum 6ml of blood in each), in either: NIPT samples must not be refrigerated."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If the sample is not transported to the laboratory immediately, store at room"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "temperature and then send as soon as practically possible. NIPT samples should be received by the laboratory in \u2264 2 working days of sample draw (FASP NIPT- S02)."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "Transporting the sample"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT laboratories are responsible for providing:"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Specialist cell stabilising tubes"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT request forms"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Packaging for sample transport"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The method of sample transport from the maternity service to the laboratory"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "The process for transporting an NIPT blood sample is outlined below."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The laboratory will have processes in place for:"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Recording receipt of the NIPT sample"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Contacting the provider if the sample is not received within 5 calendar days of dispatch"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dealing with incomplete information on the request form"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dealing with any unacceptable samples that require a repeat (all requests including repeat samples should be tracked from request until maternity services have confirmed receipt of the results)"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Reporting NIPT results"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Results will be emailed back to the generic screening email address for each site, to be actioned appropriately."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "All women who receive a higher chance NIPT result must be offered the option of:"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "PND"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No further testing"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "In some cases, NIPT may fail to give a result. \u2018No result' is where a \u2018fit for analysis' sample was received in the laboratory and it has failed to generate a result at any point of the analytical or reporting process."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "In cases where \u2018no result' is obtained from the initial NIPT sample, providers must offer:"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "One further NIPT sample"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "PND"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No further testing"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT may fail again on the second sample."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "A woman must be \u2264  weeks of pregnancy when the first NIPT sample is taken. A second NIPT sample can be offered and taken even if the woman is more than"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "weeks, in the following cases when a:"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sample is rejected"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u2018No result' report is issued"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "FASP NIPT-S03 outlines expected turnaround times for NIPT results to maternity services."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.6,
                "text": "All NIPT results will be reported and sent to the Trust by North Thames GLH (HSL)"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "Report will be sent by encrypted email."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "NIPT results"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "NIPT results are reported as either lower chance or higher chance. A numerical value is not reported."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "NIPT results must only be reported according to the woman's choice on the conditions screened for. For example, a lower or higher chance result at term for:"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "T21, T18 and T13"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "T21 only"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "T18 and T13 only"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "NIPT screening will report individual chance results for T18 and T13. This is unlike the combined test which reports a joint chance result for these conditions. For example, when a woman chooses NIPT screening for T18 and T13 she will receive both:"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A lower or higher chance result for T18"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A lower or higher chance result for T13"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "In twin pregnancies, the higher chance result report should state that one or both babies may have the condition screened for."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.5,
                "text": "Women should expect their NIPT results around 2 weeks from sample collection. NIPT result report contents"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Only results and comments relating to the conditions screened for as part of the NHS FASP screening pathway should be included on the NIPT result report, for example T21, T18 and T13."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.7,
                "text": "The NIPT result report should include all the information listed below as a minimum."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "text": "9.7.1 Patient ID"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The report should include:"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Surname"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Forename(s)"
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS number (or equivalent)"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Hospital number"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "DOB"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 1,
                "text": "9.7.2 Sample information"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The report should include:"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sample type (please specify NIPT screening)"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of NIPT sampling"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Is this a repeat sample? Yes or No"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of sample receipt in the laboratory"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Details of requestor"
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "text": "9.7.3 Clinical information"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The report should include:"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Gestational age (in weeks and days) by ultrasound at time of NIPT sampling"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Singleton or twin pregnancy"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Chorionicity in twin pregnancy (please include one of these options: monochorionic, dichorionic or unknown)"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 1,
                "text": "9.7.4 Reporting information The report should:"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Include the date that the report was authorised in the laboratory"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Include the date the report was communicated to maternity services"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Include the title of the report (for example, NHS FASP NIPT screening result report)"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clearly state, for prenatal samples, that the result is for screening the fetal genotype, and not the woman"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In the case of a higher chance result report, include the following statement: \u2018It is recommended that prenatal diagnosis is offered to confirm this result to support personal informed choice about ongoing care and pregnancy options'"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In the case of a higher chance result report for a twin pregnancy, include a statement that one or both babies may have the condition screened for"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In the case of \u2018no result' reports, include:"
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u2018First NIPT screening sample \u2013 no result obtained' (please provide reason and state that \u2018The provider should offer one of the following (one further NIPT sampling, PND or no further testing) and inform the laboratory of the woman's decision'"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u2018Second NIPT screening sample \u2013 no result obtained' (please provide reason and state \u2018Discuss further options with the woman including no further testing or PND')"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Reporting terminology (must use NHS FASP terminology)"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The summary statement must be clear on the report, for example:"
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u2018Lower chance result for Down's syndrome'"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u2018Higher chance result for Down's syndrome \u2013 offer of prenatal diagnosis recommended'"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Do not use the terms \u2018normal', \u2018abnormal', \u2018positive' or \u2018negative'."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "A numerical value must not be reported."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Managing NIPT results"
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Women receiving a higher chance or \u2018no result' NIPT result should attend an appointment in \u2264 3 working days of maternity services receiving the result (FASP NIPT-S04.)"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "This appointment should be face to face or virtual, depending on the woman's choice, and discuss the option of:"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No further testing"
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Having PND, which should be completed in \u2264 3 working days of the woman receiving the NIPT result (FASP NIPT-S05)"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "The result should be given by a healthcare professional with knowledge"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "text": "of NIPT and the NHS FASP pathway. Healthcare professionals should provide clear and accurate documentation in line with local guidelines."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Prenatal diagnosis (PND)"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Information on PND can be found in the NHS FASP handbook and chorionic villus sampling (CVS) or amniocentesis parent information. Appointment for Fetal Medicine should be arranged as soon as possible if requested by the woman."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "PND results should be reported in \u2264 3 calendar days of sample receipt (FASP NIPT-S06)."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Data requirements and monitoring"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "As this is an evaluative rollout, PHE Screening will be collecting data and monitoring how the pathway is working to learn and make improvements where necessary."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Maternity services, screening and genomic laboratories providing NIPT screening and prenatal diagnostics are required to submit data to enable the ongoing evaluation of the national rollout of NIPT in England."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "Data is required to answer specific evaluation questions. This data will be collected either directly from:"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Maternity services"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Genomic laboratories"
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Congenital Anomaly and Rare Disease Registration"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Service (NCARDRS)"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Down's syndrome screening quality assurance support service (DQASS)"
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "Data should be submitted at regular intervals (each month or every 3 months). PHE Screening will collect this data to enable reporting of:"
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Coverage (FASP NIPT-S01)"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The choices women make at each stage of the screening pathway"
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timely receipt of NIPT sample (FASP NIPT-S02)"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT test turnaround times (FASP NIPT-S03)"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timeliness of information and support to women (FASP NIPT-S04)"
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timeliness of PND (FASP NIPT-S05)"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "text": "PND test turnaround times (FASP NIPT-S06)"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Rate of NIPT \u2018no results'"
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Performance of NIPT in singleton and twin pregnancies"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Performance of NIPT in detecting T21, T18 and T13."
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "NIPT performance"
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "NIPT is a screening test and is not 100% accurate. This is because the cffDNA is derived from the placenta, not the baby itself."
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "Some women who receive a higher chance NIPT result will have a baby that does not have one of the conditions screened for."
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Some women who receive a lower chance NIPT result will have a baby with one of the conditions screened for. This is rare but can happen, in particular, when a woman has a very high chance result from the combined or quadruple test, for example 1 in 2 to 1 in"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "There is uncertainty around the performance of NIPT, particularly in T18 and T13. It is suggested this happens because babies with T18 and T13 have smaller placentas, but the reasons are not fully understood."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.5,
                "text": "Current literature review and data modelling suggest that of the NIPT screening results:"
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 0,
                "text": "About 90% will be lower chance"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "text": "About 8% will be higher chance"
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Fewer than 5% will give no result"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.6,
                "text": "Current literature review and data modelling also suggest that:"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Over 90% of women (9 out of 10) with higher chance NIPT results for T21 will be pregnant with a baby who has the condition"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Over 80% of women (8 out of 10) with higher chance NIPT results for"
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "text": "either T18 or T13 will be pregnant with a baby who has the condition"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There will be some women with higher chance NIPT results who will be pregnant with a baby who does not have any of the conditions screened for"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Screening safety incidents"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "A screening safety incident is any unintended or unexpected incident or incidents that could have or did lead to harm to one or more persons who are eligible for NHS screening. This also applies to staff working in the screening programmes."
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "Each site to report on Datix reporting system and reviewed by the Screening Team and SIAF sent to PHE team for investigation and further actions. In accordance with managing safety incidence in NHS screening programmes (PHE document)."
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "NHS FASP recommends all healthcare professionals who are involved in the offer of screening for T21, T18 and T13 in England, complete the \u2018NIPT \u2013 evaluative rollout' e-learning resource."
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "This resource includes a full version, which should be completed by healthcare professionals who have not completed the old NIPT cascade training"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "These resources are available on e-learning for Healthcare (e-LfH). All providers are responsible for making sure staff receive sufficient time to complete minimum training requirements. This is to maintain an effective screening workforce and includes continuing professional development (CPD)."
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "All providers should maintain a record of training."
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.5,
                "text": "Further information on education and training can be found in the NHS FASP handbook."
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.6,
                "text": "Guideline management"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.6.1 As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Infection prevention"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "All staff must follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "All staff must ensure that they follow Trust guidelines on infection control, using Aseptic Non-Touch Technique (ANTT) when carrying out procedures i.e. obtaining blood samples."
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy and Policy (register number 08076), the Corporate Clinical Audit and Quality Improvement Project Plan and the Maternity annual audit work plan; to encompass national and local audit and clinical governance identifying key harm themes. The Women's and Children's Clinical Audit Group will identify a lead for the audit."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "The findings of the audit will be reported to and approved by the Multi-disciplinary Risk Management Group (MRMG) and an action plan with named leads and"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "text": "timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.3,
                "text": "The audit report will be reported to the monthly Directorate Governance Meeting (DGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.4,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Safety Group within the integrated learning report."
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "All policies, procedures and guidelines will be approved locally by the Maternity and Gynaecology Practice Steering Group prior to submission to the Controlled Document team for ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "It is the Guidelines and Audit Nurse's and author's responsibility to inform the Maternity and Gynaecology Practice Steering Group and appropriate Maternity Services' staff of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to appendix 2)"
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Screening for Down's syndrome, Edwards syndrome and Patau's syndrome: NIPT \u2013 Gov.uk. Available at https://www.gov.uk/government/publications/screening-for- downs-syndrome-edwards-syndrome-and-pataus-syndrome-non-invasive-prenatal- testing-nipt/screening-for-downs-syndrome-edwards-syndrome-and-pataus- syndrome-nipt"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Non-invasive prenatal testing (NIPT) in your pregnancy"
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "type": "image",
            "sequence_num": 236,
            "data": {
                "url": "MSEGL-21029 NIPT Screening for Down's Syndrome Edward's and Patau's 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Non Invasive Prenatal testing (NIPT) in your pregnancy"
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT is a technique that is used to screen for T21, T18 and T13 during pregnancy. It involves taking a sample of blood from the woman."
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The maternal blood contains a mixture of maternal DNA and placental DNA. This is known as the total cell free DNA (cfDNA). In most cases, the placental DNA will be the same as the baby's DNA. The contribution of DNA from the placenta is called cell free fetal DNA (cffDNA)."
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "cffDNA can  be  detected  in  the  maternal  blood  as  early  as   weeks  of pregnancy. cffDNA remains in the maternal blood for only a few hours after each pregnancy, making it suitable for pregnancy-specific testing."
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cells in the human body typically contain 46 chromosomes \u2013 23 from the mother and 23 from the  father.  Each  chromosome  has  sequences  of DNA that  are  specific  to  that chromosome. NIPT uses cffDNA in the maternal blood to assess the chance of the baby having T21, T18 or T13."
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.0,
                "text": "The  majority  of cfDNA comes  from  the  woman,  usually  consisting  of  approximately 90% DNA from the woman's cells and 10% DNA from the placenta. If the baby has T21, there  should  be  slightly  more  chromosome   than  expected  from  the placental DNA (cffDNA) in the maternal blood. The same will apply for chromosomes 18 and"
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Accuracy"
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT is a screening test and is not 100% accurate. This is because the cffDNA is derived from the placenta, not the baby itself."
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Some women who receive a higher chance NIPT result will have a baby that does not have one of the conditions screened for."
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Some women who receive a lower chance NIPT result will have a baby with one of the conditions screened for. This is rare but can happen, in particular, when a woman has a very high chance result from the combined or quadruple test, for example 1 in 2 to 1 in"
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is uncertainty around the performance of NIPT, particularly in T18 and T13. It is suggested this happens because babies with T18 and T13 have smaller placentas, but the reasons are not fully understood."
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Current literature review and data modelling suggest that of the NIPT screening results:"
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "text": "about 90% will be lower chance about 8% will be higher chance fewer than 5% will give no result"
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Current literature review and data modelling also suggest that:"
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 0,
                "text": "over 90% of women (9 out of 10) with higher chance NIPT results for T21 will be pregnant with a baby who has the condition"
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 0,
                "text": "over 80% of women (8 out of 10) with higher chance NIPT results for either T18 or T13 will be pregnant with a baby who has the condition"
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 0,
                "text": "there will be some women with higher chance NIPT results who will be pregnant with a baby who does not have any of the conditions screened for"
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Results"
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Screening results take approx. 2 weeks to return from sample being taken,"
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Screening team will contact you to inform of results \u2013 your choice whether to receive these results face to face or by phone."
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In cases where a result cannot be obtained a repeat sample can be taken on one more occasion or the option of prenatal diagnosis testing can be offered or no further testing. If a second sample fails to achieve a result, prenatal diagnosis can be offered if required or no further testing."
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If NIPT result reports a lower chance result \u2013 no further action will be taken"
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If NIPT result reports a higher chance result - the following options would then be discussed -"
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No further action"
            },
            "type": "ListItem",
            "sequence_num": 260
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prenatal diagnosis for confirmation"
            },
            "type": "ListItem",
            "sequence_num": 261
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If considering not continuing with pregnancy prenatal diagnosis would be required."
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT Screening for Down's, Edward's and Patau's Syndrome / MSEGL-21029/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NIPT Screening for Down's, Edward's and Patau's Syndrome / MSEGL-21029/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: NIPT Screening for Down's, Edward's and Patau's Syndrome/MSEGL-21029 (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "type": "table",
            "sequence_num": 268,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 269,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Implement new Non Invasive Prenatal Testing for Edward's Down's and Patau's Syndrome"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Recommendations from the UK National Screening Committee"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and Clinicians"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to Pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 270,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Neate / Bethany Broadhurst / Emma Connolly"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Antenatal and Newborn Screening Co-ordinators"
                    },
                    {
                        "text": "25 May 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 271
        }
    ]
}